Dougan M, Azizad M, Mocherla B, Gottlieb RL, et al. A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load. Clin Infect Dis 2021 Oct 28. pii: 6413724. doi: 10.1093.
PMID: 34718468